DMCCB Basel Symposium 2024

This one-day symposium is organized by the Swiss Chemical Society, Division Medicinal Chemistry and Chemical Biology. The goal is to stimulate a stronger cooperation among persons working in different areas of medicinal chemistry and chemical biology. Scientists from applied and fundamental research, from industry, education, and regulation are welcome.

Speakers:

Gerard JP Van Westen, Leiden University
«Artificial Intelligence in Early Drug Discovery Towards Virtual Drug Discovery and Safety Assessment?»
Nadine Schneider, Novartis
«From computer-aided drug design to computer-accelerated drug discovery»
Jennifer Müller, ETH Zurich
«Development of Novel LAT1 Ligands as Potential Antitumor Agents»
Lukas Schneider, University of Basel
«Recording binding information directly into DNA-encoded libraries using terminal deoxynucleotidyl transferase»
Andrea Volkamer, Universität des Saarlandes
«Open-Source Developments for Data Driven Kinase-Centric Drug Design»
Hongming Chen, Guangzhou Laboratory
«Development of novel generative models for molecule design»
Patrick Barth, EPFL Lausanne
«Computational design of membrane receptor therapeutics»
Chris Baker, Syngenta
«Generative Chemistry for Weed Control: A Collaboration between Syngenta and In Silico Medicine»

Organizing Committee
Dr. Christoph Sager, leadXpro: Chair of the symposium
Prof. Nina Hartrampf, University of Zurich
Prof. Dennis Gillingham, University of Basel
Prof. Jean-Louis Reymond, University of Bern

Registration
28.01.2024  Registration deadline for abstract submission and participants
31.01.2024 Notification of acceptance
On site registration is possible, but may cause queue time

Please register via the event website on https://dmccb24.scg.ch/